Nurix Therapeutics Inc (NRIX) — Capital Reinvestment Ratio
Latest as of November 2023:
0.10x
Nurix Therapeutics Inc (NRIX) has a Capital Reinvestment Ratio of 0.10x as of November 2023, meaning it reinvests 0% of its operating cash flow ($26.69 Million) in capital expenditures ($2.58 Million). See Nurix Therapeutics Inc (NRIX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.10x
Capex / Operating Cash Flow
Operating Cash Flow
$26.69 Million
USD
Capital Expenditures
$2.58 Million
USD
Data as of
Nov 2023
Most recent filing
Nurix Therapeutics Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Nurix Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Nurix Therapeutics Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Nurix Therapeutics Inc from 2019 to 2019. For live market cap and broader valuation context, see Nurix Therapeutics Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 2.75x | $601.00K | $1.65 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow